ArticleInvestigational new drugs2019

Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer.

Laura W Goff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.